The trusted source for
healthcare information and
Minneapolis-based Medtronic recently announced FDA’s approval to market its Medtronic SynchroMed EL infusion system, an implantable drug infusion system that delivers medication directly into the fluid surrounding the spinal cord.
The system has already helped nearly 50,000 patients with cancer and nonmalignant pain, or spasticity due to cerebral palsy, brain injury, multiple sclerosis, spinal cord injury, and stroke.
The SynchroMed EL system adds about three years to the battery life before replacement, depending on dosage. Average time between replacement surgeries also is extended over the original SynchroMed, from four to seven years. The EL system also can be programmed to deliver doses as small as 48 µl per day.
• INS Advanced Concepts in the Manage ment of Central Venous Access Devices in the Alternate Care Setting: July 31, Hyatt Regency Hotel, Chicago. Call (800) 694-0298.
• National Association for Home Care 18th Annual Meeting and Home Care Expo: Oct. 9-13, San Diego Convention Center. Call (202) 547-7424.
• HIDA/99 Trade Show: Oct. 9-11, Navy Pier Convention Center, Chicago. Call (703) 549-4432.
• CINA 1999: Oct. 20-22, Toronto. Call (416) 292-0687 or go to web.idirect.com/~csotcina.
• Medtrade 1999: Nov. 3-6, 1999, Ernest N. Morial Convention Center, New Orleans. Call (770) 641-8181.
• 1999 Fall National Academy of Intravenous Therapy: Nov. 5-7, Westin Hotel Copley Place, Boston. Call (617) 441-3008.
• Medtrade 2000: Oct. 3-6, 2000, Orange County Convention Center, Orlando, FL. Call (770) 641-8181.